Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective

Overview of attention for article published in Lupus Science & Medicine, February 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#11 of 439)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 14 news stories from 14 outlets.

WASHINGTON, Feb. 14, 2023 /PRNewswire/ -- Lupus is a complicated and debilitating autoimmune disease, affecting millions of…

WASHINGTON, Feb. 14, 2023 /PRNewswire/ -- Lupus is a complicated and debilitating autoimmune disease, affecting millions of…

WASHINGTON, Feb. 14, 2023 /PRNewswire/ -- Lupus is a complicated and debilitating autoimmune disease, affecting millions of…

WASHINGTON, Feb. 14, 2023 /PRNewswire/ -- Lupus is a complicated and debilitating autoimmune disease, affecting millions of…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 10 additional news stories.